The Maternal Outcomes and its Determinants among Pregnant Women Complicated by Severe Preeclampsia at Hidar 11 Hospital


The Maternal Outcomes and its Determinants among Pregnant Women Complicated by Severe Preeclampsia at Hidar 11 Hospital


NIGUSS CHERIE1, AHMED MOHAMMED2

1Department of public health, Wollo University, Ethiopia
2Asayta Hospital, Afar, Ethiopia


International Research Journal of Public Health-2D code

Background: Pre-eclampsia is one of the causes of maternal morbidity and mortality throughout the world. It is common problem in developing countries. This study was aimed to assess the maternal outcomes of severe pre-eclampsia among pregnant women admitedand managed at at Hidar 11 Hospital in 2018.
Methods: A cross-sectional study was conducted among preeclamptic women who were admitted to maternity ward of at Hidar 11 Hospital in a four year period from JAN 1/ 2014 – Decem 31/ 2018. All laboring mothers that are admitted and managed at hidar 11 hospitals was a source population retrieved by review of clinical records and then, the data was collected from April 1-30 2018. Daily completeness of the questionnaire was cross checked by principal investigator for data quality control using prepared checklist after a pretest given. Data regarding patient characteristics and treatment outcome (eg. maternal death, maternal complication, hospital stay) were collected. Data was collected using data collection format from patient medical charts. data was cleaned coded entered and analyzed using SPSS version 20. Descriptive statistics and logistic regression were used. All the statistical tests were significant at P-value < 0.05,Besides odd ratio 95%CI was used.
Results: A total of 318 mothers’ medical charts were reviewed. One hundred sixty five (82.5%) pregnant women were diagnosed with severe preeclampsia. About 98(30.8%) of the women developed complications. The most common maternal complication was HELLP syndrome Mothers with gestational age less than 34weeks were 6.8 times more likely to develop complication [AOR=6.8, 95% CI = 1.974-24.026].similarly primigravida 4 times more likely to develop complication[AOR=4.934 CI =2.281-10.675 ]. Mothers with antipartum preeclampsia were 6.6 times more likely to have prolonged hospital stay [AOR=6.611 ,95% CI=2.749-15.898].
Conclusion: The commonly seen poor treatment outcomes in preclamptic mothers were magnesium sulphate toxicity, prolonged hospital stay and development of complications. Preeclampsia at gestational age of less than 34 weeks significantly increases the risk of developing maternal complication.


Keywords: Maternal outcome, pre-eclampsia

Free Full-text PDF

How to cite this article:
NIGUSS CHERIE and AHMED MOHAMMED.The Maternal Outcomes and its Determinants among Pregnant Women Complicated by Severe Preeclampsia at Hidar 11 Hospital.International Research Journal of Public Health, 2018; 2:24.. DOI:10.28933/irjph-2018-11-2908


References

1. Sibai B, Chames M. Chronic Hypertension in Pregnancy. Glob Libr Women’s Med. 2008.
2. Carl H, Kara M, Pamela M, Leandro C, Craig A, Peter J. Maternal preeclampsia and neonatal outcomes. J Pregnancy. 2011; 22: 1-7.
3. Moore-Maxwell CA, Robboy SJ. Placental site trophoblastic tumor arising from antecedent molar pregnancy. Gynecol Oncol 2004; 92:708.
4. Gaym A, Bailey P, BLuwei P, Admasu K, Gebrehiwot Y. Disease burden due to pre-eclampsia/eclampsia and the Ethiopian health system’s response. Int J Gynecol Obstet. 2011; 115: 112-116.
5. Bharti C. Role of 2 gram calcium supplementation in prevention of pre-eclampsia in high risk cases. JEMDS. 2013; l2: 7205-7210.
6. Osungbade K, Ige O. Public health perspectives of preeclampsia in developing countries: implication for health system strengthening. J Pregnancy 2011; 48: 10-95.
7. Zenebe W, Hailemariam S, Mirkuzie W. Hypertensive disorders of pregnancy in jimma university specialized hospital. Ethiop J Health Sci. 2011; 21: 147-154.
8. Savita R, Deepika P, Anshu S, Smiti N. Maternal and perinatal outcome in sever preeclampsia and eclampsia. South Asian Federation of Obstetrics and Gynaecology. 2009; 1: 25-28.
9. Maternal mortality in 2005: Estimates developed by WHO, UNICEF, UNIFPA and the World Bank, Geneva, World Health Organization, 2007.
10. Sultana A, Aparna J. Risk factors for pre-eclampsia and its perinatal outcome. Ann Biol Res. 2013; 4: 1-5
11. Kassie GM, Negussie D, Ahmed JH. Maternal outcomes of magnesium sulphate and diazepam use in women with severe pre-eclampsia and eclampsia in Ethiopia. Pharm Pract. 2014; 12: 400.
12. Zenebe W, Hailemariam S, Mirkuzie W. Hypertensive disorders of pregnancy in jimma university specialized hospital. Ethiop J Health Sci. 2011; 21: 147-154.
13. Duffy CR, Odibo AO, Roehl KA, Macones GA, Cahill AG. Effect of magnesium sulfate on fetal heart rate patterns in the second stage of labor. Obstet Gynecol. 2012; 119: 1129-1136.
14. Altman D, Carroli G, Duley L, Farrell B, Moodley J, Neilson J, et al. Do women with preeclampsia and their babies, benefit from magnesium sulphate? The Magpie trial: a randomised and placebo-controlled trial. Lancet 2002; 359: 1877-1890.
15. Duley L, Gulmezoglu AM, Henderson-Smart DJ. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia (Cochrane Review). Oxford: The WHO Reproductive Health Library CD-ROM No. 10; 2007.
16. Duley L, Gulmezoglu AM, Henderson-Smart DJ, Chou D. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev. 2010; 11: CD000025.
17. Muganyizi P, Shagdara M. Predictors of extra care among magnesium sulphate treated eclamptic patients at Muhimbili National Hospital, Tanzania. BMC Pregnancy Childbirth. 2011; 11: 41.
18. Gupta T, Gupta N, Jain J, Gupta S, Bhatia P, Bagla J. Maternal and perinatal outcome in patients with severe preeclampsia/eclampsia with and without help syndrome. Journal of Universal College of Medical Sciences. 2013; 1: 7-12
19. Sujittra J, Somchai T. Perinatal Outcomes in Severe Preeclamptic Women between 24-33+6 Weeks’ Gestation. J Med Assoc Thai. 2008; 91: 25-30
20. Khan I. Magnesium sulfate versus diazepam infusion in eclampsia, Annals of KEMU. 2009; 15: 149-151.
21. Altman D, Carroli G, Duley L, Farrell B, Moodley J, Neilson J, et al. Magpie Trial Collaboration Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo controlled trial. Lancet. 2002; 359: 1877-1890.
22. Seid I, et al. Maternal Outcomes of Preeclampsia in an Ethiopian Gynecologic Hospital. Ann Med Health Sci Res. 2017; 7: 16-21
23. Maereg e tal, Trends of preeclampsia/eclampsia and maternal and neonatal outcomes Pan Afr Med J,addisababa, Ethiopia, 2016; 25(Suppl 2): 12
24. Wubanchi T. e tal.patterns of hypertensive disorders of pregnancy and associated factors atdebrebiorhan hospital Ethiop Med J, 2015, Supp. 2
25. Lisonkovaetal. Maternal Morbidity Associated With Early-Onset and Late-Onset Preeclampsia study done in Washington State). Obstetrics & Gynecology: October 2014 – Volume 124 – Issue 4 – p 771–781
26. Amorim MM, e tal, Maternal outcomes according to mode of delivery in women with severe preeclampsia J Matern Fetal Neonatal Med. 2015 Apr;28(6):654-60
27. Ugwu EO e tal.Maternal and perinatal outcome of severe pre-eclampsia Niger J ClinPract. in Enugu, Nigeria 2011 Oct-Dec;14(4):418-21.
28. Smith Aetal, Pregnancy and severe chronic hypertension: maternal outcome.Hypertens.Pregnancy. 2004;23(3):285-93.
29. Prakash J, Pandey LK, Singh AK, KarB.Hypertension in pregnancy: Hospital based study. J Assoc Physicians of India, 2006; 54:273-278.
30. Cooke et al. Incidence, aetiology and outcomes of Obstetric-related acute kidney injury in Malawi: BMC Nephrology (2018) 19:25
31. J. Moodey. Maternal death associated with hypertensive disorders of pregnancy: A population based study. Hypertension in pregnancy, 2005; 23: 247-256.
32. Seyometal.Maternal and fetal outcome of pregnancy related hypertension in Mettu Karl Referral Hospital, EthiopiaJournal of Ovarian Research (2015) 8:10
33. Seid I, et al. Maternal Outcomes of Preeclampsia in an Ethiopian Gynecologic Hospital. Ann Med Health Sci Res. 2017; 7: 16-21
34. Maereg e tal, Trends of preeclampsia/eclampsia and maternal and neonatal outcomes Pan Afr Med J,addisababa, Ethiopia, 2016; 25(Suppl 2): 12
35. Swamy MK, Patil K, Nageshu S. Maternal and perinatal outcome during expectant management of severe pre-eclampsia between 24 and 34 weeks of gestation. J ObstetGynaecol India. 2012; 62: 413-418
36. Sibai BM. Preeclampsia as a cause of preterm and late preterm (near-term) births. SeminPerinatol. 2006; 30: 16-19.